EUR 26.78
(2.53%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 19.1 Million EUR | -12.15% |
2022 | 21.75 Million EUR | 25.59% |
2021 | 17.32 Million EUR | 29.63% |
2020 | 13.36 Million EUR | 43.02% |
2019 | 9.34 Million EUR | 15.3% |
2018 | 8.1 Million EUR | 18.29% |
2017 | 6.85 Million EUR | 22.67% |
2016 | 5.58 Million EUR | -14.05% |
2015 | 6.49 Million EUR | 1036.17% |
2014 | -694 Thousand EUR | -116.0% |
2013 | 4.33 Million EUR | 1611.5% |
2012 | -287 Thousand EUR | -107.34% |
2011 | 3.91 Million EUR | 871.4% |
2010 | -507 Thousand EUR | 37.79% |
2009 | -815 Thousand EUR | -130.58% |
2008 | 2.66 Million EUR | 0.0% |
2005 | 2.27 Million EUR | 323.18% |
2004 | -1.01 Million EUR | 68.37% |
2003 | -3.21 Million EUR | 58.25% |
2002 | -7.7 Million EUR | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q3 | 4.2 Million EUR | 2.44% |
2024 Q1 | 3.6 Million EUR | -50.06% |
2024 Q2 | 4.1 Million EUR | 13.89% |
2023 Q2 | 3.2 Million EUR | -23.81% |
2023 Q1 | 4.2 Million EUR | -25.7% |
2023 FY | 19.1 Million EUR | -12.15% |
2023 Q4 | 7.2 Million EUR | 60.2% |
2023 Q3 | 4.5 Million EUR | 40.63% |
2022 FY | 21.75 Million EUR | 25.59% |
2022 Q2 | 5.4 Million EUR | 14.89% |
2022 Q1 | 4.7 Million EUR | -14.87% |
2022 Q4 | 5.65 Million EUR | -5.78% |
2022 Q3 | 6 Million EUR | 11.11% |
2021 Q2 | 3.4 Million EUR | -8.11% |
2021 Q4 | 5.52 Million EUR | 17.47% |
2021 FY | 17.32 Million EUR | 29.63% |
2021 Q1 | 3.7 Million EUR | -36.88% |
2021 Q3 | 4.7 Million EUR | 38.24% |
2020 Q4 | 5.86 Million EUR | 102.14% |
2020 Q3 | 2.9 Million EUR | 11.54% |
2020 Q2 | 2.6 Million EUR | 30.0% |
2020 Q1 | 2 Million EUR | -46.57% |
2020 FY | 13.36 Million EUR | 43.02% |
2019 FY | 9.34 Million EUR | 15.3% |
2019 Q1 | 2.1 Million EUR | -12.61% |
2019 Q2 | 500 Thousand EUR | -76.19% |
2019 Q3 | 3 Million EUR | 500.0% |
2019 Q4 | 3.74 Million EUR | 24.77% |
2018 Q2 | 2.1 Million EUR | 31.25% |
2018 Q3 | 2 Million EUR | -4.76% |
2018 Q1 | 1.6 Million EUR | -17.95% |
2018 Q4 | 2.4 Million EUR | 20.15% |
2018 FY | 8.1 Million EUR | 18.29% |
2017 Q3 | 1.9 Million EUR | 11.76% |
2017 FY | 6.85 Million EUR | 22.67% |
2017 Q4 | 1.95 Million EUR | 2.63% |
2017 Q2 | 1.7 Million EUR | 21.43% |
2017 Q1 | 1.4 Million EUR | -16.86% |
2016 Q3 | 1.6 Million EUR | 14.29% |
2016 Q1 | 1 Million EUR | 25.47% |
2016 FY | 5.58 Million EUR | -14.05% |
2016 Q2 | 1.4 Million EUR | 40.0% |
2016 Q4 | 1.68 Million EUR | 5.25% |
2015 Q2 | 2.8 Million EUR | 86.67% |
2015 Q3 | 1.4 Million EUR | -50.0% |
2015 Q4 | 797 Thousand EUR | -43.07% |
2015 FY | 6.49 Million EUR | 1036.17% |
2015 Q1 | 1.5 Million EUR | 168.37% |
2014 Q1 | 1 Million EUR | -25.26% |
2014 FY | -694 Thousand EUR | -116.0% |
2014 Q4 | -2.19 Million EUR | -213.43% |
2014 Q2 | 1.2 Million EUR | 20.0% |
2014 Q3 | -700 Thousand EUR | -158.33% |
2013 Q1 | 900 Thousand EUR | 253.32% |
2013 FY | 4.33 Million EUR | 1611.5% |
2013 Q2 | 1 Million EUR | 11.11% |
2013 Q4 | 1.33 Million EUR | 21.64% |
2013 Q3 | 1.1 Million EUR | 10.0% |
2012 FY | -287 Thousand EUR | -107.34% |
2012 Q1 | 200 Thousand EUR | 205.82% |
2012 Q2 | -800 Thousand EUR | -500.0% |
2012 Q3 | 900 Thousand EUR | 212.5% |
2012 Q4 | -587 Thousand EUR | -165.22% |
2011 Q2 | 900 Thousand EUR | 28.57% |
2011 Q3 | 2.7 Million EUR | 200.0% |
2011 FY | 3.91 Million EUR | 871.4% |
2011 Q4 | -189 Thousand EUR | -107.0% |
2011 Q1 | 700 Thousand EUR | 186.74% |
2010 Q1 | -200 Thousand EUR | 36.51% |
2010 FY | -507 Thousand EUR | 37.79% |
2010 Q2 | -200 Thousand EUR | 0.0% |
2010 Q4 | -807 Thousand EUR | -200.88% |
2010 Q3 | 800 Thousand EUR | 500.0% |
2009 Q4 | -315 Thousand EUR | -415.0% |
2009 Q2 | -400 Thousand EUR | -100.0% |
2009 Q1 | -200 Thousand EUR | 0.0% |
2009 FY | -815 Thousand EUR | -130.58% |
2009 Q3 | 100 Thousand EUR | 125.0% |
2008 FY | 2.66 Million EUR | 0.0% |
2005 FY | 2.27 Million EUR | 323.18% |
2004 FY | -1.01 Million EUR | 68.37% |
2003 FY | -3.21 Million EUR | 58.25% |
2002 FY | -7.7 Million EUR | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
BBS-Bioactive Bone Substitutes Oyj | -3.48 Million EUR | 648.54% |
Modulight Oyj | -11.86 Million EUR | 261.108% |
Nexstim Plc | -1.32 Million EUR | 1539.455% |